Vitamin B and Choline Supplements Could Slow Glaucoma Progression, Mouse Study Finds

New research suggests that vitamin B and choline supplements may slow the progression of glaucoma. A mouse study shows promising potential for nutritional interventions in eye health.
Vitamin B and Choline Supplements Could Slow Glaucoma Progression, Mouse Study Finds
Two supplements may help slow down the progression of glaucoma, according to recent research.
Glaucoma is a group of eye diseases that can damage the optic nerve and potentially cause blindness. While there is no cure yet, treatments aim to slow its progression. Previous studies suggest that a healthy diet rich in certain nutrients can lower risk, including omega-3 fatty acids, vitamins B3, A, C, and antioxidants like lutein and zeaxanthin.
A new study published in Cell Reports Medicine indicates that supplementation with B vitamins and choline may help slow glaucoma progression, based on mouse models. Researchers focused on how these nutrients impact the retina and optic nerve health.
Study Highlights:
- The study examined the role of homocysteine, an amino acid involved in protein synthesis, which in high levels has been linked to health issues and eye disease progression.
- Surprisingly, elevated homocysteine did not worsen glaucoma in mice, suggesting it may be a bystander rather than a direct cause.
- Supplementation with B6, B9 (folate), B12, and choline was shown to halt or slow optic nerve damage, even in aggressive glaucoma models.
- The effect appears to be independent of intraocular pressure, a common target in glaucoma treatment.
- Researchers are now planning clinical trials to explore these findings in humans.
Expert Opinions:
- Dr. David Geffen notes that supplementing with vitamins could be a groundbreaking adjunct therapy, especially since glaucoma has no cure and treatments can become less effective.
- Dr. Benjamin Bert emphasizes that any discovery helping to prevent or slow glaucoma is promising, especially with increasingly aging populations.
This research opens new avenues for managing glaucoma through nutritional support, offering hope for non-invasive, accessible interventions.
For more information, read the full study here.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Promising Results from Shortened Immunotherapy Duration for Advanced Melanoma in Clinical Trial
A groundbreaking clinical trial suggests that stopping immunotherapy after one year may be as effective as two years for advanced melanoma, potentially reducing side effects and treatment burden.
Inflammation in Reproductive Tract May Affect Fertility, Hormone Therapy Shows Promise
Inflammation within the female reproductive system may impair fertility, but hormone-based therapies show potential in reducing inflammation and improving pregnancy chances, according to recent studies.
Breakthrough Research Offers Hope for Innovative Treatments for Spinal Muscular Atrophy and Autism
New research highlights the role of mitochondria in neurological disorders like SMA and autism, opening pathways for innovative and safer treatments. Discover how cellular energy regulators influence brain development and neuron degeneration.
FDA Approves Gilead's Biannual Injection for HIV Prevention in the US
The FDA has approved Gilead's groundbreaking twice-yearly injection to prevent HIV, offering a powerful new tool in the fight against the virus with over 99.9% efficacy demonstrated in clinical trials.